Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Aloxi incorporated in NCCN antiemetic guidelines for CINV

March 18, 2004

TopoTarget and deCODE collaborate on improved cancer treatments

March 18, 2004

Targeting telomerase for multiple myeloma therapy

March 18, 2004

Submission of final section of Onco TCS rolling NDA

March 17, 2004

European approval for Faslodex

March 17, 2004

XL-119 receives orphan drug status for bile duct tumors

March 17, 2004

FDA Advisory Committee sets date to review RSR-13 NDA

March 17, 2004

New alphav integrin inhibitors and their use reported by Sigma-Tau

March 17, 2004

Biomar presents a novel cytotoxic agent isolated from fungal cultures

March 17, 2004

Geron and Merix enter coexclusive license agreement for cancer vaccines

March 17, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...